Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome

Hematol Oncol. 2019 Dec;37(5):652-654. doi: 10.1002/hon.2650. Epub 2019 Aug 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / diagnosis
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Leukemia, Myeloid, Chronic-Phase / genetics*
  • Leukemia, Myeloid, Chronic-Phase / mortality
  • Polymerase Chain Reaction
  • Prognosis
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use*
  • Remission Induction
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Protein Kinase Inhibitors